He is also the Co-Director of the Thoracic Oncology Program at the Department of Internal Medicine which is part of the University of Michigan Health System. His clinical interests include malignant mesothelioma care and treatment, lung cancer, thoracic cancer, and the epidemiology of lung cancer and thymoma. His research interest is in experimental therapeutics. Within the Department of Internal Medicine, Dr. Kalemkerian’s specialties are in hematology and oncology, as well as thoracic oncology.